Replies to post #395799 on Amarin Corp Plc (AMRN)

[rosemountbomber]

Has Amarin communicated their concerns to the FDA?

This is what I don’t understand about the EU reimbursements:

The budget constraints only affect new drug reimbursements? Why, if a new drug, provides more value and benefit per dollar can’t they scratch an already reimbursed drug that is crap and sub the new one in?